July 28, 2025

For Immediate Release

Vincent DeMarco, president of the Maryland Health Care for All! Coalition, released the following statement today:

“The Maryland Health Care For All Coalition commends our state’s Prescription Drug Affordability Board for their historic step in making a preliminary finding that critically needed diabetes drugs Farxiga and Jardiance cause affordability challenges for the state. We urge the Prescription Drug Affordability Board to as soon as possible put a reasonable upper payment limit on what state and local governments pay for these life-saving drugs which could save Maryland taxpayers millions of dollars. We look forward to the Prescription Drug Affordability Board next year using its authority under legislation enacted this year to also make these and other high cost drugs more affordable for all Marylanders. Drugs don’t work if people can’t afford them.”

Last modified: July 29, 2025